06 Nov Molecular characterisation of the residual disease after neoadjuvant endocrine therapy in ER+/HER2- breast cancer uncovers biomarkers of tumour response

ID: 03314

Authors: López-Velazco, Joanna I. (1); Manzano, Sara (1); Elorriaga, Kepa (2); Otaño, María (3); Álvarez-Huesa, Uxue (1); Rezola, Marta (2); Adradas, Vera (4); Zugazagoitia, Jon (4); Paré, Laia (5); Prat, Aleix (5); Álvarez-López, Isabel (1,3); M. Caffarel, María (1,6); Urruticoechea, Ander (1,3)

Topic: DRUG TOLERANCE